Action Alert: Tell Congress to Increase OCRP Funding
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through. Deadline is March 25th! … Continued
News
Statement from Audra Moran, President and CEO of Ovarian Cancer Research Alliance on the President’s FY2020 Budget
(March 12, 2019) “The President’s proposed FY2020 budget released by the White House on Monday seeks to cut medical research funding at the National Cancer Institute (NCI) by 15 percent … Continued
OCRA’s Advocate Leader Program is now open. Apply today.
OCRA’s Advocate Leader Program is now open. Apply today.
Be a voice for the ovarian cancer community. Update: The deadline to apply for our 2019 Advocate Leader program has now passed. (August 28, 2018) Registration is now open for … Continued
Meet Sayla, OCRA Advocate Leader
Name: Sayla H.Hometown: Portland, ORStatus: In treatmentAdvocacy Goal: Oral Parity, Access to Care Sayla was diagnosed earlier last year and is currently in treatment. She’s determined to use her experience … Continued
Meet Elise, OCRA Advocate Leader
Name: Elise D.Hometown: Durham, NHStatus: 13-Year SurvivorAdvocacy Goal: Access to Care Elise feels lucky that she was diagnosed with early-stage ovarian cancer, and being an Advocate Leader allows her to … Continued
OCRFA’s Response to Trump Administration’s Birth Cont...
OCRFA’s Response to Trump Administration’s Birth Control Coverage Rollback
(Oct. 11, 2017) Last week, the Trump Administration issued a regulation to immediately allow employers to deny insurance coverage for birth control on the basis of their own moral or … Continued
Dept. of Health and Human Services Seeks to Limit Access to...
Dept. of Health and Human Services Seeks to Limit Access to Oral Contraception Benefits
According to recent reports, the Department of Health and Human Services (HHS) will soon seek to limit access to oral contraception benefits. “The proposed rule allowing employers to deny insurance … Continued
Action Alert: Protect Federal Funding for Ovarian Cancer Re...
Action Alert: Protect Federal Funding for Ovarian Cancer Research
The White House has released a proposed budget for FY2018 that makes drastic cuts to the budgets for the National Institute of Health (NIH) and Centers for Disease Control and … Continued
Federal Funding for Ovarian Cancer: 2016 Highlights
Federal Funding for Ovarian Cancer: 2016 Highlights
As the voice for women with ovarian cancer on Capitol Hill, OCRFA fights to secure funding for ovarian cancer research and education at the federal level. In 2016, with the … Continued
Kolker Fellowship Deadline Approaching
Kolker Fellowship Deadline Approaching
The Kolker Fellowship commemorates the legacy of pioneering health policy advocate Ann Kolker. At the time Ann was diagnosed with ovarian cancer in 1996, she was already a political powerhouse, having … Continued
OCRFA applauds FDA’s statement on ovarian cancer screening ...
OCRFA applauds FDA’s statement on ovarian cancer screening test
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated. The FDA states, “despite extensive … Continued
Action Alert: Oral Chemotherapy Parity
Action Alert: Oral Chemotherapy Parity
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. … Continued